Y. Graham, M. Agrawal, R. Campbell, M. Haber, and C. Collis, Ulcer Prevention in Long-term Users of Nonsteroidal Anti-inflammatory Drugs, Archives of Internal Medicine, vol.162, issue.2, pp.169-175, 2002.
DOI : 10.1001/archinte.162.2.169

M. Peek and M. Blaser, HELICOBACTER PYLORI AND GASTROINTESTINAL TRACT ADENOCARCINOMAS, Nature Reviews Cancer, vol.2, issue.1, pp.28-37, 2002.
DOI : 10.1038/nrc703

P. Malfertheiner, F. Megraud, O. Morain, C. Bazzoli, F. El-omar et al., Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report, Gut, vol.56, issue.6, pp.772-781, 2007.
DOI : 10.1136/gut.2006.101634

D. Dammann, R. Folsch, E. Hahn, D. Kleist, and H. Klor, Eradication of H. pylori with Pantoprazole, Clarithromycin, and Metronidazole in Duodenal Ulcer Patients: A Head-to-Head Comparison Between Two Regimens of Different Duration, Helicobacter, vol.37, issue.1, pp.41-51, 2000.
DOI : 10.1023/A:1018882804607

M. Gerhard, R. R. Prinz, C. Naumann, and M. , Pathogenesis of Helicobacter pylori infection, Helicobacter, vol.122, issue.s1, pp.17-23, 2002.
DOI : 10.1136/gut.48.6.765

F. Glupczynski, F. Megraud, M. López-brea, and L. Andersen, European multicenter survey of in vitro antimicrobial resistance in Helicobacter pylori, Eur J Clin Microbiol Infect Dis, vol.11, pp.820-823, 2000.

F. Mégraud, Surveillance de la résistance de Helicobacter pylori aux antibiotiques, pp.327-329, 2000.

K. Parsons, M. Carter, D. Sanders, T. Winstanley, and A. Lobo, Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status, Alimentary Pharmacology and Therapeutics, vol.29, issue.9, pp.1473-1478, 2001.
DOI : 10.1016/S0002-9270(98)00824-7

N. Vakil, Helicobacter pylori Treatment: A Practical Approach, The American Journal of Gastroenterology, vol.10, issue.6, pp.497-499, 2006.
DOI : 10.1111/j.1523-5378.2003.00179.x

G. Bergsson, O. Steingrimsson, and H. Thormar, Bactericidal effects of fatty acids and monoglycerides on Helicobacter pylori, International Journal of Antimicrobial Agents, vol.20, issue.4, pp.258-262, 2002.
DOI : 10.1016/S0924-8579(02)00205-4

N. Das, Antibiotic-like action of essential fatty acids, Can Med Assoc J, vol.123, p.1350, 1985.

R. Knapp and M. A. , Bactericidal Effects of Polyunsaturated Fatty Acids, Journal of Infectious Diseases, vol.154, issue.1, pp.84-94, 1986.
DOI : 10.1093/infdis/154.1.84

B. Petschow, R. Batema, and L. Ford, Susceptibility of Helicobacter pylori to bactericidal properties of medium chain monoglycerides and free fatty acids, Antimicrob Agents Chemother, vol.40, issue.2, pp.302-306, 1996.

L. Thompson, A. Cockayne, and R. Spiller, Inhibitory effect of polyunsaturated fatty acids on the growth of Helicobacter pylori: a possible explanation of the effect of diet on peptic ulceration., Gut, vol.35, issue.11, pp.1557-1561, 1994.
DOI : 10.1136/gut.35.11.1557

N. Das, G. Devi, K. Rao, and M. Rao, Prostaglandins can modify gamma-radiation and chemical induced cytotoxicity and genetic damage in vitro and in vivo, Prostaglandins, vol.38, issue.6, pp.689-716, 1989.
DOI : 10.1016/0090-6980(89)90050-6

A. Tamawski, D. Hollander, and H. Gergely, Protection of the gastric mucosa by linoleic acid -a nutrient essential fatty acid, Clin Invest Med, vol.10, pp.132-135, 1987.

A. Sands, Inactivation and Inhibition of Replication of the Enveloped Bacteriophage ??6 by Fatty Acids, Antimicrobial Agents and Chemotherapy, vol.12, issue.4, pp.523-530, 1977.
DOI : 10.1128/AAC.12.4.523

A. Lee, J. O-'rourke, D. Ungria, M. Robertson, B. Daskalopoulos et al., A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain, Gastroenterology, vol.112, issue.4, pp.1386-1397, 1997.
DOI : 10.1016/S0016-5085(97)70155-0

D. Israel, N. Salama, C. Arnold, S. Moss, and T. Ando, Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses, Journal of Clinical Investigation, vol.107, issue.5, pp.611-620, 2001.
DOI : 10.1172/JCI11450
URL : http://www.jci.org/articles/view/11450/files/pdf

A. Lee, J. O-'rourke, M. Ungria, B. Robertson, and A. Daskalopoulos, A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain, ) A standardized mouse model of Helicobacter pylori Infection: Introducing the Sydney Strain, pp.1386-1397, 1997.
DOI : 10.1016/S0016-5085(97)70155-0

R. Ferrero, J. Thiberge, M. Huerre, and A. Labigne, Immune responses of specific-pathogen-free mice to chronic Helicobacter pylori (strain SS1) infection, Infect Immun, vol.66, pp.1349-1355, 1998.

J. Van-zanten, T. Kolesnikow, V. Leung, J. O-'rourke, and A. Lee, Gastric Transitional Zones, Areas where Helicobacter Treatment Fails: Results of a Treatment Trial Using the Sydney Strain Mouse Model, Antimicrobial Agents and Chemotherapy, vol.47, issue.7, pp.2249-2255, 2003.
DOI : 10.1128/AAC.47.7.2249-2255.2003

A. Eaton, J. Danon, S. Krakowka, and E. Weisbrode, A reproducible scoring system for quantification of histologic lesions of inflammatory disease in mouse gastric epithelium, Comp Med, vol.57, issue.1, pp.57-65, 2007.

R. Development and C. Team, R: A language and environment for statistical computing. R Foundation for Statistical Computing, 2011.

Y. Hochberg, A sharper Bonferroni procedure for multiple tests of significance, Biometrika, vol.75, issue.4, pp.800-802, 1988.
DOI : 10.1093/biomet/75.4.800

M. Sorberg, M. Nillson, M. Hanberger, and E. Nillson, Morphologic conversion ofHelicobacter pylori from bacillary to coccoid form, European Journal of Clinical Microbiology & Infectious Diseases, vol.41, issue.Supplement 181, pp.216-219, 1996.
DOI : 10.1111/j.1365-2672.1987.tb02685.x

T. Furuyashiki and S. Narumiya, Stress responses: the contribution of prostaglandin E2 and its receptors, Nature Reviews Endocrinology, vol.265, issue.3, pp.163-175, 2011.
DOI : 10.1016/j.physbeh.2009.04.004

M. Roomi, N. Roomi, T. Kalinovsky, A. Niedzwiecki, and M. Rath, In vivo and in vitro effect of a nutrient mixture on a human hepatocarcinoma cell line SK- HEP-1, Exp Oncol, vol.32, issue.2, pp.84-91, 2010.

D. Kelley, D. Siegel, M. Vemuri, and B. Mackey, Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men, Am J Clin Nutr, vol.86, pp.324-333, 2007.
DOI : 10.1089/met.2011.0081

A. Duggan, J. Atherton, A. Cockayne, M. Balsitis, and S. Evision, Clarification of the link between polyunsaturated fatty acids and Helicobacter pylori-associated duodenal ulcer disease: a dietary intervention study, British Journal of Nutrition, vol.3, issue.04, pp.515-522, 1997.
DOI : 10.1079/BJN19890070

B. Borgstrom, A. Dalhqvist, G. Lundh, and J. Sjoval, Studies of Intestinal Digestion and Absorption in the Human1, Journal of Clinical Investigation, vol.36, issue.10, pp.1521-1536, 1957.
DOI : 10.1172/JCI103549

K. Kuriki, K. Wakai, and K. Matsuo, Gastric Cancer Risk and Erythrocyte Composition of Docosahexaenoic Acid with Anti-inflammatory Effects, Cancer Epidemiology Biomarkers & Prevention, vol.16, issue.11, pp.2406-2415, 2007.
DOI : 10.1158/1055-9965.EPI-07-0655

C. Chaput, A. Labigne, and I. Boneca, Characterization of Helicobacter pylori Lytic Transglycosylases Slt and MltD, Journal of Bacteriology, vol.189, issue.2, pp.844-852, 2006.
DOI : 10.1128/JB.01270-06
URL : https://hal.archives-ouvertes.fr/pasteur-00139176